Telomere length and mitochondrial DNA copy number in multidrug-resistant tuberculosis.
Sign Up to like & getrecommendations! Published in 2021 at "Tuberculosis"
DOI: 10.1016/j.tube.2021.102144
Abstract: Multidrug resistant tuberculosis (MDR-TB) is a severe disease that requires prolonged chemotherapy and is associated with an increased probability of treatment failure and death. MDR-TB is a state of heightened oxidative stress and inflammation, which… read more here.
Keywords: mdr; telomere length; mdr patients; tuberculosis ... See more keywords
Diagnostic assistance method for RR-TB/MDR-TB patients under treatment based on CNN-LSTM
Sign Up to like & getrecommendations! Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-21955-x
Abstract: The rapid development of deep learning has promoted its application in disease diagnosis, treatment, and prognosis prediction. Medical imaging plays a crucial role in the management of rifampicin-resistant tuberculosis/multidrug-resistant tuberculosis (RR-TB/MDR-TB). In particular, chest computed… read more here.
Keywords: treatment; cnn lstm; model; mdr patients ... See more keywords
Frequency and characteristics of TB relapses
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa2895
Abstract: Introduction: Orel oblast, Russia, as a WHO pilot region implemented regional TB Control programme in 1999-2013. In 2002 -2014 the region provided treatment of 4532 non-MDR-TB patients and 633 MDR-TB patients. Treatment success rate for… read more here.
Keywords: non mdr; mdr; frequency; treatment ... See more keywords
Linezolid Experience Among MDR-TB Patients in Mumbai
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa3486
Abstract: Background: India has 25% of the world’s tuberculosis. Mumbai is home to 12% of India’s cases that are resistant to rifampin and isoniazid (MDR-TB), but they are often resistant to standard treatment. Linezolid (LZD) resistance… read more here.
Keywords: experience among; culture conversion; lzd; mdr patients ... See more keywords
Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia
Sign Up to like & getrecommendations! Published in 2019 at "BMC Public Health"
DOI: 10.1186/s12889-019-6500-3
Abstract: BackgroundMultidrug-resistant tuberculosis (MDR-TB) is caused by bacteria that are resistant to the most effective anti-tuberculosis drug. The MDR-TB is an increasing global problem and the spread of MDR-TB has different recovery time for different patients.… read more here.
Keywords: mdr; recovery time; time; mdr patients ... See more keywords
Weight variation increases the risk of death during the intensive phase of treatment among MDR-TB patients: A retrospective study
Sign Up to like & getrecommendations! Published in 2023 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.39.4.7025
Abstract: Objective: To estimate the predictors of death during intensive phase of Multidrug resistant tuberculosis treatment according to the weight of patients at the time of diagnosed. Methods: A retrospective study was conducted at three public… read more here.
Keywords: phase treatment; death; intensive phase; mdr patients ... See more keywords
Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0218487
Abstract: Background Hypothyroidism is one of the adverse drug reactions that associated with Multidrug Resistant Tuberculosis (MDR-TB) medications. Extremely variable magnitude of hypothyroidism in MDR-TB patients has been reported from different parts of the world. However,… read more here.
Keywords: hypothyroidism; patients treatment; treatment; mdr patients ... See more keywords
A Score to Predict the Risk of Major Adverse Drug Reactions Among Multi-Drug Resistant Tuberculosis Patients in Southern Ethiopia, 2014–2019
Sign Up to like & getrecommendations! Published in 2022 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s351076
Abstract: Background Adverse events (AE) contribute to poor drug adherence and withdrawal, which contribute to a low treatment success rate. AE are commonly reported among multi-drug resistance tuberculosis (MDR-TB) patients in Ethiopia. However, predictors of AE… read more here.
Keywords: southern ethiopia; among multi; score; risk ... See more keywords
Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1
Sign Up to like & getrecommendations! Published in 2025 at "Antibiotics"
DOI: 10.3390/antibiotics14020204
Abstract: Background/Objectives: Studies show that SNPs in ABCB1 rs2032582 and SLCO1B1 rs4149015 affect the PK profile of moxifloxacin, a key drug for MDR-TB. This study aimed to assess the genotype frequencies of ABCB1 rs2032582 and SLCO1B1… read more here.
Keywords: analysis; mdr patients; abcb1; patients indonesia ... See more keywords
The Association of Chronic Pulmonary Aspergillosis and Chronic Pulmonary Histoplasmosis with MDR-TB Patients in Indonesia
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Fungi"
DOI: 10.3390/jof10080529
Abstract: In Indonesia, 2.4% of all new tuberculosis patients had multi-drug resistant disease (MDR-TB); an estimated 24,000 incidences. Historical case series of MDR-TB described a high frequency of cavitation and poor prognosis. The diagnosis of chronic… read more here.
Keywords: mdr patients; chronic pulmonary; cpa; mdr ... See more keywords